Global and United States Ovarian Cancer Market Report & Forecast 2023-2028

Report ID: 1861523 | Published Date: Oct 2024 | No. of Page: 92 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Ovarian Cancer Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Ovarian Cancer Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Ovarian Cancer Market Size for the Year 2017-2028
        1.2.2 Global Ovarian Cancer Market Size for the Year 2017-2028
    1.3 Ovarian Cancer Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Ovarian Cancer in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Ovarian Cancer Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Ovarian Cancer Market Dynamics
        1.4.1 Ovarian Cancer Industry Trends
        1.4.2 Ovarian Cancer Market Drivers
        1.4.3 Ovarian Cancer Market Challenges
        1.4.4 Ovarian Cancer Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Ovarian Cancer by Type
    2.1 Ovarian Cancer Market Segment by Type
        2.1.1 Surgery
        2.1.2 Chemotherapy
        2.1.3 Radiation
        2.1.4 Biological Therapy
    2.2 Global Ovarian Cancer Market Size by Type (2017, 2022 & 2028)
    2.3 Global Ovarian Cancer Market Size by Type (2017-2028)
    2.4 United States Ovarian Cancer Market Size by Type (2017, 2022 & 2028)
    2.5 United States Ovarian Cancer Market Size by Type (2017-2028)
3 Ovarian Cancer by Application
    3.1 Ovarian Cancer Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Others
    3.2 Global Ovarian Cancer Market Size by Application (2017, 2022 & 2028)
    3.3 Global Ovarian Cancer Market Size by Application (2017-2028)
    3.4 United States Ovarian Cancer Market Size by Application (2017, 2022 & 2028)
    3.5 United States Ovarian Cancer Market Size by Application (2017-2028)
4 Global Ovarian Cancer Competitor Landscape by Company
    4.1 Global Ovarian Cancer Market Size by Company
        4.1.1 Top Global Ovarian Cancer Companies Ranked by Revenue (2021)
        4.1.2 Global Ovarian Cancer Revenue by Player (2017-2022)
    4.2 Global Ovarian Cancer Concentration Ratio (CR)
        4.2.1 Ovarian Cancer Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Ovarian Cancer in 2021
        4.2.3 Global Ovarian Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Ovarian Cancer Headquarters, Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Ovarian Cancer Headquarters and Area Served
        4.3.2 Global Ovarian Cancer Companies Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Ovarian Cancer Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Ovarian Cancer Market Size by Company
        4.5.1 Top Ovarian Cancer Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Ovarian Cancer Revenue by Players (2020, 2021 & 2022)
5 Global Ovarian Cancer Market Size by Region
    5.1 Global Ovarian Cancer Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Ovarian Cancer Market Size by Region (2017-2028)
        5.2.1 Global Ovarian Cancer Market Size by Region: 2017-2022
        5.2.2 Global Ovarian Cancer Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Ovarian Cancer Market Size YoY Growth 2017-2028
        6.1.2 North America Ovarian Cancer Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Ovarian Cancer Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Ovarian Cancer Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Ovarian Cancer Market Size YoY Growth 2017-2028
        6.3.2 Europe Ovarian Cancer Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Ovarian Cancer Market Size YoY Growth 2017-2028
        6.4.2 Latin America Ovarian Cancer Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Ovarian Cancer Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Ovarian Cancer Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Bristol Myers Squibb
        7.1.1 Bristol Myers Squibb Company Details
        7.1.2 Bristol Myers Squibb Business Overview
        7.1.3 Bristol Myers Squibb Ovarian Cancer Introduction
        7.1.4 Bristol Myers Squibb Revenue in Ovarian Cancer Business (2017-2022)
        7.1.5 Bristol Myers Squibb Recent Development
    7.2 Eli Lilly
        7.2.1 Eli Lilly Company Details
        7.2.2 Eli Lilly Business Overview
        7.2.3 Eli Lilly Ovarian Cancer Introduction
        7.2.4 Eli Lilly Revenue in Ovarian Cancer Business (2017-2022)
        7.2.5 Eli Lilly Recent Development
    7.3 GlaxoSmithKline
        7.3.1 GlaxoSmithKline Company Details
        7.3.2 GlaxoSmithKline Business Overview
        7.3.3 GlaxoSmithKline Ovarian Cancer Introduction
        7.3.4 GlaxoSmithKline Revenue in Ovarian Cancer Business (2017-2022)
        7.3.5 GlaxoSmithKline Recent Development
    7.4 Janssen Pharmaceuticals
        7.4.1 Janssen Pharmaceuticals Company Details
        7.4.2 Janssen Pharmaceuticals Business Overview
        7.4.3 Janssen Pharmaceuticals Ovarian Cancer Introduction
        7.4.4 Janssen Pharmaceuticals Revenue in Ovarian Cancer Business (2017-2022)
        7.4.5 Janssen Pharmaceuticals Recent Development
    7.5 Novogen
        7.5.1 Novogen Company Details
        7.5.2 Novogen Business Overview
        7.5.3 Novogen Ovarian Cancer Introduction
        7.5.4 Novogen Revenue in Ovarian Cancer Business (2017-2022)
        7.5.5 Novogen Recent Development
    7.6 Genentech
        7.6.1 Genentech Company Details
        7.6.2 Genentech Business Overview
        7.6.3 Genentech Ovarian Cancer Introduction
        7.6.4 Genentech Revenue in Ovarian Cancer Business (2017-2022)
        7.6.5 Genentech Recent Development
    7.7 Aetera Zenteris
        7.7.1 Aetera Zenteris Company Details
        7.7.2 Aetera Zenteris Business Overview
        7.7.3 Aetera Zenteris Ovarian Cancer Introduction
        7.7.4 Aetera Zenteris Revenue in Ovarian Cancer Business (2017-2022)
        7.7.5 Aetera Zenteris Recent Development
    7.8 Boehringer Ingelheim
        7.8.1 Boehringer Ingelheim Company Details
        7.8.2 Boehringer Ingelheim Business Overview
        7.8.3 Boehringer Ingelheim Ovarian Cancer Introduction
        7.8.4 Boehringer Ingelheim Revenue in Ovarian Cancer Business (2017-2022)
        7.8.5 Boehringer Ingelheim Recent Development
    7.9 Roche
        7.9.1 Roche Company Details
        7.9.2 Roche Business Overview
        7.9.3 Roche Ovarian Cancer Introduction
        7.9.4 Roche Revenue in Ovarian Cancer Business (2017-2022)
        7.9.5 Roche Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Ovarian Cancer Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Ovarian Cancer Market Trends
    Table 3. Ovarian Cancer Market Drivers
    Table 4. Ovarian Cancer Market Challenges
    Table 5. Ovarian Cancer Market Restraints
    Table 6. Global Ovarian Cancer Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Ovarian Cancer Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Ovarian Cancer Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Ovarian Cancer Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Ovarian Cancer Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Ovarian Cancer Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Ovarian Cancer Revenue Share by Player, 2017-2022
    Table 13. Global Ovarian Cancer Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Ovarian Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovarian Cancer as of 2021)
    Table 15. Top Players of Ovarian Cancer in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Ovarian Cancer Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Ovarian Cancer Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Ovarian Cancer Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Ovarian Cancer Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Ovarian Cancer Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Ovarian Cancer Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Ovarian Cancer Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Ovarian Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Ovarian Cancer Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Ovarian Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Ovarian Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Ovarian Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Bristol Myers Squibb Company Details
    Table 31. Bristol Myers Squibb Business Overview
    Table 32. Bristol Myers Squibb Ovarian Cancer Product
    Table 33. Bristol Myers Squibb Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 34. Bristol Myers Squibb Recent Development
    Table 35. Eli Lilly Company Details
    Table 36. Eli Lilly Business Overview
    Table 37. Eli Lilly Ovarian Cancer Product
    Table 38. Eli Lilly Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 39. Eli Lilly Recent Development
    Table 40. GlaxoSmithKline Company Details
    Table 41. GlaxoSmithKline Business Overview
    Table 42. GlaxoSmithKline Ovarian Cancer Product
    Table 43. GlaxoSmithKline Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 44. GlaxoSmithKline Recent Development
    Table 45. Janssen Pharmaceuticals Company Details
    Table 46. Janssen Pharmaceuticals Business Overview
    Table 47. Janssen Pharmaceuticals Ovarian Cancer Product
    Table 48. Janssen Pharmaceuticals Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 49. Janssen Pharmaceuticals Recent Development
    Table 50. Novogen Company Details
    Table 51. Novogen Business Overview
    Table 52. Novogen Ovarian Cancer Product
    Table 53. Novogen Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 54. Novogen Recent Development
    Table 55. Genentech Company Details
    Table 56. Genentech Business Overview
    Table 57. Genentech Ovarian Cancer Product
    Table 58. Genentech Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 59. Genentech Recent Development
    Table 60. Aetera Zenteris Company Details
    Table 61. Aetera Zenteris Business Overview
    Table 62. Aetera Zenteris Ovarian Cancer Product
    Table 63. Aetera Zenteris Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 64. Aetera Zenteris Recent Development
    Table 65. Boehringer Ingelheim Company Details
    Table 66. Boehringer Ingelheim Business Overview
    Table 67. Boehringer Ingelheim Ovarian Cancer Product
    Table 68. Boehringer Ingelheim Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 69. Boehringer Ingelheim Recent Development
    Table 70. Roche Company Details
    Table 71. Roche Business Overview
    Table 72. Roche Ovarian Cancer Product
    Table 73. Roche Revenue in Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 74. Roche Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ovarian Cancer Product Picture
    Figure 2. Global Ovarian Cancer Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Ovarian Cancer Market Size 2017-2028 (US$ Million)
    Figure 4. United States Ovarian Cancer Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Ovarian Cancer Market Size 2017-2028 (US$ Million)
    Figure 6. United States Ovarian Cancer Market Share in Global 2017-2028
    Figure 7. Ovarian Cancer Report Years Considered
    Figure 8. Product Picture of Surgery
    Figure 9. Product Picture of Chemotherapy
    Figure 10. Product Picture of Radiation
    Figure 11. Product Picture of Biological Therapy
    Figure 12. Global Ovarian Cancer Market Share by Type in 2022 & 2028
    Figure 13. Global Ovarian Cancer Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Ovarian Cancer Market Share by Type (2017-2028)
    Figure 15. United States Ovarian Cancer Market Share by Type in 2022 & 2028
    Figure 16. United States Ovarian Cancer Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Ovarian Cancer Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Clinics
    Figure 20. Product Picture of Others
    Figure 21. Global Ovarian Cancer Market Share by Application in 2022 & 2028
    Figure 22. Global Ovarian Cancer Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Ovarian Cancer Market Share by Application (2017-2028)
    Figure 24. United States Ovarian Cancer Market Share by Application in 2022 & 2028
    Figure 25. United States Ovarian Cancer Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Ovarian Cancer Market Share by Application (2017-2028)
    Figure 27. North America Ovarian Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Ovarian Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Ovarian Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Ovarian Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Ovarian Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. UAE Ovarian Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Bristol Myers Squibb Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 56. Eli Lilly Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 57. GlaxoSmithKline Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 58. Janssen Pharmaceuticals Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 59. Novogen Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 60. Genentech Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 61. Aetera Zenteris Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 62. Boehringer Ingelheim Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 63. Roche Revenue Growth Rate in Ovarian Cancer Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
Novogen
Genentech
Aetera Zenteris
Boehringer Ingelheim
Roche
Frequently Asked Questions
Ovarian Cancer report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ovarian Cancer report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ovarian Cancer report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Overbed Tables

Overbed Tables market is segmented by region (country), players, by Type and by Application. Play ... Read More

Ozone Generators

Ozone Generators market is segmented by region (country), players, by Type and by Application. Pl ... Read More